FDA's New Import Program for 2018

Website https://www.traininng.com/webinar/fda's-new-import-program-for-2018--200439live?ourglocal-Dec-Seo-20 | Edit Freely

Category Import Brokers, Investors, Logistics Managers, Sales Managers

Deadline: December 08, 2018 | Date: December 10, 2018

Venue/Country: Online, U.S.A

Updated: 2018-11-13 17:54:38 (GMT+9)

Call For Papers - CFP

The FDA and U.S. Customs and Border Protection are using new import requirements. The FDA's import software screening program (PREDICT) and the U.S. Custom's ACE software program require more information from the foreign source(s). FDA's product codes and U.S. Harmonized Tariff Schedule (HTS) link the requirements. The software coding information must be correct. Otherwise, you face costly delays and possibly a refusal of the entry.

Why should you Attend

The new import entry filing requirements became effective in 2016 and are posing problems for user. Failure to provide the correct information creates costly delays and, in some cases, the frustrating task of contacting the FDA to resolve the problem. FDA's software screening program, PREDICT, and U.S. Custom's ACE program require careful attention. Errors will cost money. The less obvious software is the FDA's and U.S. Custom's linking of your legal requirements by using the correct Harmonized Tariff Schedule (HTS) code.

Areas Covered in the Session

FDA's required information for the PREDICT software screening prior to entry

FDA product codes

Custom's required information for the ACE software system prior to entry

Custom's Harmonized Tariff Schedule (HTS)

Affirmation of Compliance (AOC)

Who Will Benefit

Business Planning Executives

Regulatory Managers

In-house Legal Counsel and Contract Specialists

Venture Capitalists

Business Acquisition Executives

Speaker Profile

Casper (Cap) Uldriks, through his firm “Encore Insight LLC,” brings over 32 years of experience from the FDA. He specialized in the FDA’s medical device program as a field investigator, served as a senior manager in the Office of Compliance and an Associate Center Director for the Center for Devices and Radiological Health.